Surgical Power System
Guizhou Zirui Technology Co., Ltd. · Decision date Sep 11, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-09-11 for K254174, a Surgical Power System submitted by Guizhou Zirui Technology Co., Ltd. of Zunyi, China, with Nanos Medical Shanghai Limited listed as correspondent. The submission was received 12/23/2025 and reviewed under regulation 882.4360 in the Neurology panel, with primary classification product code HBC and subsequent codes EQJ, ERL, HBE, HBF and HWE. The device classification name on the record is Motor, Drill, Electric.
SESE means the submission was cleared as substantially equivalent to a predicate device; it is not a PMA approval. The record describes a traditional 510(k) not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan. The public page does not state which components or modifications were the subject of the submission, the predicate device, or any clinical or performance data supporting the decision.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Neurology
- Decision date
- Sep 11, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K254174
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Guizhou Zirui Technology Co., Ltd.
- Product code
- HBC
- Decision code
- SESE
- Decision date
- Sep 11, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Motor, Drill, Electric.
- Applicant
- Guizhou Zirui Technology Co., Ltd.
- Product code
- HBC
- FDA device class
- 2
FDA decision timeline
K254174 received
Application receipt date recorded by FDA.
K254174 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Guizhou Zirui Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Zunyi
Sources and methodology
- Original FDA record: K254174
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records